654 related articles for article (PubMed ID: 23291583)
21. Brentuximab vedotin in anaplastic large cell lymphoma.
Skarbnik AP; Smith MR
Expert Opin Biol Ther; 2012 May; 12(5):633-9. PubMed ID: 22449148
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
[TBL] [Abstract][Full Text] [Related]
23. Pediatric case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma forming a solitary skin tumor on the forearm.
Tokuyama M; Kurashige Y; Ota T; Manabe Y; Yamaoka H; Ikoma N; Fukumura A; Miyashita M; Otsubo K; Morimoto T; Mochizuki H; Nakano N; Nakamura N; Ozawa A; Mabuchi T
J Dermatol; 2017 Apr; 44(4):465-467. PubMed ID: 27864829
[TBL] [Abstract][Full Text] [Related]
24. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
25. Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature.
Cao Q; Liu F; Li S; Liu N; Li L; Li C; Peng T
Diagn Pathol; 2016 Sep; 11(1):83. PubMed ID: 27612448
[TBL] [Abstract][Full Text] [Related]
26. Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
Agrusa JE; Egress ER; Lowe EJ
Front Immunol; 2023; 14():1203471. PubMed ID: 37275877
[TBL] [Abstract][Full Text] [Related]
27. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.
Chuang SS; Hsieh YC; Ye H; Hwang WS
Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487
[TBL] [Abstract][Full Text] [Related]
28. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
29. Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature.
Yu L; Yan LL; Yang SJ
Int J Clin Exp Pathol; 2014; 7(8):4806-16. PubMed ID: 25197351
[TBL] [Abstract][Full Text] [Related]
30. Unusual variants of intravascular malignant hematopoietic neoplasms: a report of 4 cases and review of the literature.
Nguyen GH; Yassin AH; Magro CM
Am J Dermatopathol; 2015 May; 37(5):360-7. PubMed ID: 25803724
[TBL] [Abstract][Full Text] [Related]
31. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
32. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
33. Immunohistopathological features of anaplastic large-cell lymphoma according to anaplastic lymphoma kinase expression and bone marrow involvement pattern.
Park SH; Chi HS; Cho YU; Jang S; Park CJ
Histopathology; 2013 Jul; 63(1):13-8. PubMed ID: 23656317
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous anaplastic large-cell lymphoma presenting with hemophagocytic syndrome: a case report and review of the literature.
Shimizu Y; Tanae K; Takahashi N; Kohri M; Arai E; Bessho M; Niitsu N
Leuk Res; 2010 Feb; 34(2):263-6. PubMed ID: 19640585
[TBL] [Abstract][Full Text] [Related]
35. Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy.
Onaka T; Kitagawa T; Kawakami C; Yonezawa A
Turk J Haematol; 2018 May; 35(2):135-136. PubMed ID: 29391331
[No Abstract] [Full Text] [Related]
36. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.
Ju E; Adigun C; Dunphy C; Gold S; Morrell DS
Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
